ArticleFrontiers in pharmacology2026
Synergistic effect of octenidine gel and hydrogel dressing in the treatment of venous leg ulcers.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Venous leg ulcers (VLUs) represent a major chronic wound condition associated with high recurrence rates, prolonged healing, and substantial socioeconomic burden. Hydrogels have recently gained attention as effective wound dressings due to their moisture-retentive and biocompatible properties. This study aimed to evaluate the clinical effectiveness of a combined therapy using octenidine gel and a hydrogel dressing compared to a silver-containing calcium alginate dressing in patients with VLUs. Methods: A randomized controlled trial was conducted, enrolling 60 patients with chronic VLUs. Participants were randomly assigned to either an experimental group (octenidine gel + hydrogel dressing) or a control group (silver-containing calcium alginate dressing). Wound healing progress was assessed using the RESVECH 2.0 Scoring Scale, which evaluates six wound parameters of effective wound healing. Measurements were taken at baseline and after 4 weeks of treatment. Results: After 4 weeks, the experimental group showed statistically significant improvements in wound size, wound edges, tissue in the wound bed, exudate, infection/inflammation signs, and overall RESVECH 2.0 total score. No significant changes were observed in the control group. Between-group comparisons confirmed superior healing outcomes in the experimental group. Discussion: The combination of octenidine gel and a hydrogel dressing significantly enhanced healing outcomes in patients with VLUs compared to conventional silver-containing dressings, suggesting that hydrogel-based antiseptic therapy is an effective alternative for VLU management. Given the chronic nature and high recurrence rates of VLUs, incorporating hydrogel-based antiseptic dressings into standard treatment protocols may improve patient outcomes and reduce healing time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.